As part of the collaboration, RDL has adopted Aushon's technology for simultaneously measuring protein biomarker panels for several autoimmune indications.
Kindstar has been granted exclusive rights to market the SLE-Key Rule-Out test in China, which will be the initial product offering stemming from the partnership.
The collaboration will leverage DiaSorin's Liaion MDX PCR system, and Tecan's Fluent Laboratory Automation Solution to provide users a complete sample-to-result system.
Under today's deal, all of UC Health's medical centers will work with GeneDx and have access to more than 400 of the firm's tests for rare hereditary disorders.
Xifin customers will be able to access lab services in support of consumer-initiated testing and employer-based screening programs, as part of the deal.
The collaborations will evaluate whether patient-specific ex vivo cancer immunotherapy assays can predict in vivo efficacy, and ACEA's cell analysis platform.